Global Blood Therapeutics (GBT) PT Lowered to $124 at Roth Capital
Tweet
Share
E-mailGet Alerts GBT Hot Sheet
Price: $68.49 --0%
Rating Summary:
12 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
12 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Roth Capital analyst Elemer Piros lowered the price target on Global Blood Therapeutics (NASDAQ: GBT) to $124.00 (from $128.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- DNB ASA (DNB:NO) (DNHBY) PT Raised to NOK305 at JPMorgan
- TUI AG (TUI1:GR) (TUIFY) PT Lowered to EUR7.20 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
